Clinical Trials Directory

Trials / Conditions / 2019-nCoV

2019-nCoV

12 registered clinical trials studyying 2019-nCoV.

StatusTrialSponsorPhase
UnknownCOVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1
NCT04356508
Dr Gerry Gin Wai KwokPhase 2
TerminatedPersonalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary
NCT04321928
University of PecsN/A
SuspendedHydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
NCT04334967
Providence Health & ServicesPhase 4
UnknownTreatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients
NCT04264858
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyN/A
UnknownEvaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Stand
NCT04273763
Second Affiliated Hospital of Wenzhou Medical UniversityN/A
UnknownClinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children
NCT04270383
Beijing Children's Hospital—
TerminatedEvaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Corona
NCT04261907
First Affiliated Hospital of Zhejiang UniversityN/A
UnknownThe Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia
NCT04261426
Peking Union Medical College HospitalPhase 2 / Phase 3
CompletedClinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus
NCT04260594
Jieming QUPhase 4
UnknownA Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pn
NCT04254874
Tongji HospitalPhase 4
UnknownA Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumon
NCT04255017
Tongji HospitalPhase 4
WithdrawnPrognositc Factors in COVID-19 Patients Complicated With Hypertension
NCT04272710
Chongqing Medical University—